$2.69 $0.07 (2.7%)

10:05 AM EDT on 07/22/19

Auris Medical (NASDAQ:EARS)

CAPS Rating: 1 out of 5

Current Price $2.69 Mkt Cap $0.00
Open $2.84 P/E Ratio 0.00
Prev. Close $2.62 Div. (Yield) $0.00 (0.0%)
Daily Range $2.69 - $2.84 Volume 14,798
52-Wk Range $2.42 - $10.88 Avg. Daily Vol.

Caps

How do you think NASDAQ:EARS will perform against the market?

Add Stock to CAPS Watchlist

All Players

5 Outperform
8 Underperform
 

All-Star Players

2 Outperform
4 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:EARS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

shanelofgren (31.61)
Submitted July 28, 2016

This one is a bit tricky to value, so I will spend most of my time with a newsflow oriented pitch instead.But as a simple valuation, top down, you have cap of 142, with net cash most likely in the range of 25. So, platform and pipeline are currently… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:EARS VS S&P 500 (SPY)

NASDAQ:EARS Summary

Fools bullish on NASDAQ:EARS are also bullish on:

Fools bearish on NASDAQ:EARS are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about EARS.

Recs

0
Member Avatar KingMR012 (< 20) Submitted: 10/8/2018 6:24:12 PM : Outperform Start Price: $0.60 NASDAQ:EARS Score: +332.94

Upcoming phase 3 clinical trial to be released as product for tinnitus and sudden hearing loss. This will be a great for people with inner ear disorders and complications.

Recs

0
Member Avatar superstar2 (99.38) Submitted: 8/18/2016 10:50:10 AM : Outperform Start Price: $2.21 NASDAQ:EARS Score: -17.64

Good news for vulture buyers: This Switzerland-based company stated its TACTT2 trial with Keyzilen(TM) for acute inner ear tinnitus missed its primary efficacy endpoints.

Recs

0
Member Avatar roymarshall (55.65) Submitted: 1/5/2016 5:41:32 PM : Outperform Start Price: $6.10 NASDAQ:EARS Score: -107.20

If the trend continues for the week, this is better than I had originally expected. I was thinking 7 by end of the week, but looks 8

Leaderboard

Find the members with the highest scoring picks in EARS.

Score Leader

KingMR012

KingMR012 (< 20) Score: +332.94

The Score Leader is the player with the highest score across all their picks in EARS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
KingMR012 < 20 10/9/2018 Outperform 5Y $0.60 +336.67% +3.73% +332.94 1 Comment
cashole 99.88 6/6/2019 Underperform 5Y $2.93 -10.58% +5.00% +15.58 0 Comment
Momentum21 85.09 9/29/2016 Outperform 5Y $1.74 +50.57% +37.87% +12.70 0 Comment
whatsthepoint 99.98 6/5/2019 Underperform 5Y $2.56 +2.34% +5.50% +3.15 0 Comment
shake656 38.87 9/14/2016 Underperform 5Y $1.70 +54.12% +39.12% -14.99 0 Comment
superstar2 99.38 8/18/2016 Outperform 5Y $2.21 +18.56% +36.20% -17.64 1 Comment
cashsage 98.87 10/16/2018 Underperform 5Y $1.44 +81.94% +6.38% -75.56 0 Comment
risktech < 20 4/11/2018 Underperform 5Y $1.37 +91.24% +13.03% -78.21 0 Comment
marctanner 23.26 1/12/2016 Outperform 5Y $5.20 -49.62% +53.65% -103.26 0 Comment
roymarshall 55.65 1/6/2016 Outperform 3W $6.10 -57.05% +50.15% -107.20 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for EARS.

Advertisement